Connect with us

COVID-19

COVID-19: Zero death as NCDC registers 138 new infections

Published

on

The Nigeria Centre for Disease Control (NCDC) says it has not recorded any death but registered 138 new cases of COVID-19 in the country as of Oct. 2.

The NCDC said on its website on Sunday morning that the additional 138 infections brought the total of infections in the country to 206,064.

The News Agency of Nigeria(NAN) reports that after days of consistent reporting of fatalities from the Coronavirus pandemic, the country on Saturday recorded no death from the disease.

The 138 fresh infections reported on Saturday represented a declined from 161 reported on Friday.

The third wave which came with the Delta variant of the virus, regarded as the most transmissible of all the variants, ravaged many states of the federation, particularly Lagos, Oyo, Rivers, Delta and the Federal Capital Territory (FCT).

YOU MAY ALSO LIKE:   Zamfara governor inaugurates 300-bed general hospital

The public health agency noted that the country recorded no new death from the virus which had claimed 2,723 lives in the country.

According to it, the FCT reported the highest number of infections with 51 cases, followed by Anambra 28 and Lagos State, the epicentre of the disease in Nigeria, with 24.

Among others were the North-central states of Benue and Plateau which recorded nine and seven cases, respectively.

Also, Kaduna and Jigawa States in the North-west recorded seven and a single case, respectively.

YOU MAY ALSO LIKE:   Kebbi governor: Presidency has pledged funds for treatment of cancer patients

It noted that the latest infections included 18 cases reported from Benue State for Sept. 30 as well as Oct. 1 and 2.

The NCDC said that the number of known active cases in Nigeria now stands at 9,386, a decrease from the 9,404 cases reported on Friday.

The publuc health agency stated that Nigeria has successfully treated and discharged 193,893 people.

It noted that a multi-sectoral national Emergency Operations Centre (EOC), activated at Level 2, continued to coordinate the national response activities.

The NCDC added that over 3,043,321 million samples of the virus from the nation’s roughly 200 million population have been tested

Share With A Friend
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

COVID-19

Brymo and manager, Lanre Lawal, parts way after 8 years

Published

on

Lanre Lawal, the long time manager of popular Nigerian singer, Brymo, has stated that he has parted ways with the artiste. The talent manager in an Instagram post thanked the singer for being a good friend.

In his farewell message, Lawal who has managed Brymo for about eight years stated that it was a mutual decision to move on to the next stage of their professional journeys individually.

The statement read, “In a statement titled, ‘Notice of disengagement between Bail Music Company and Brymo,’ Lawal wrote, “This is to inform the general public that The Bail Music Company, under the leadership of Lanre Lawal, is no longer responsible for the management of Olawale Oloforo, popularly known as Brymo.

YOU MAY ALSO LIKE:   COVID-19: US donates over 3.5 million doses of vaccine to Nigeria

“Over the last eight years as Brymo’s manager, we have built formidable relationships and partnerships with top music stakeholders in and outside Nigeria. Together, we have assisted in amplifying the strength and talents of the singer/songwriters (Brymo) through the smooth development and execution of projects that have grown the brand internationally. However, like every healthy relationship, there is a mutual decision to move on to the next stage of our professional journeys individually.

“We are proud of the years we worked together and find nothing more satisfying than to see Brymo reach the heights of his success.”

YOU MAY ALSO LIKE:   7 Untold Health Benefits Of Pap (Akamu / Ogi / Eko)

This development is coming shortly after the singer claimed in October that legendary Nigerian singer, 2baba, accused him of sleeping with his wife. Also, Brymo alleged that 2baba sent some thugs to beat him up.

Based on the allegation, the management of 2baba, Now Muzik, slammed Brymo with a lawsuit for the damning accusations he made towards his colleague, Innocent Idibia, better known as 2Baba, in a series of posts on his official Twitter page.

Share With A Friend
Continue Reading

COVID-19

Africa’s coronavirus cases pass 8.44 million

Published

on

The number of confirmed COVID-19 cases in Africa reached 8,445,917 cases as of Wednesday afternoon, the Africa Centres for Disease Control and Prevention (Africa CDC) said.

The Africa CDC, the specialised healthcare agency of the African Union (AU), said the death toll from the pandemic across the continent stands at 216,013.

Some 7,824,863 patients across the continent have recovered from the disease so far, according to the agency.

South Africa, Morocco, Tunisia and Ethiopia were among the countries with the most cases in the continent, according to the agency.

YOU MAY ALSO LIKE:   UNICEF seeks more COVID-19 vaccines in Africa to stem death

South Africa has recorded the most COVID-19 cases in Africa with 2,917,255 cases, while northern Africa’s Morocco reported 942,779 cases as of Wednesday afternoon, it was noted.

In terms of the caseload, southern Africa was the most affected region, followed by the northern and eastern parts of the continent, while central Africa was the least affected region in the continent, according to the Africa CDC.

Share With A Friend
Continue Reading

COVID-19

Nigerian government says it may expand access to coronavirus vaccination ahead of December deadline

Published

on

Following the federal government’s December deadline for civil servants to get the COVID-19 vaccination as a precondition for accessing their offices, the National Primary Healthcare Development Agency (NPHCDA) has expressed its commitment to ramping up vaccine uptake across the country.

The agency said it had put in place plans for the establishment of mass vaccination sites across the country. It also said the government had begun to work on the possibility of enhancing the security features of the vaccination cards to limit forgery.

Executive Director of NPHCDA, Dr Faisal Shuaib, said at a media briefing on Thursday in Abuja that the objective of the strategy was to vaccinate a large number of people through big sites, such as federal institutions (universities, polytechnics), shopping malls, religious centres, sporting events, conference centres, and markets.

Shuaib said the agency had already done a comprehensive analysis and forecast of COVID-19 vaccines’ availability.

He said, “We have enough vaccines to cover more than this population of federal government employees and we are expecting even much more. Based on delivery forecasts from the COVAX facility and the African Union, Nigeria will have adequate vaccines to cover more than 50% of eligible populations by the end of the first quarter of 2022.”

Shuaib explained that the agency was currently enhancing the security features of the vaccination cards in order to limit forgery.

According to him, “We are working with relevant security agencies to make examples of these individuals, who may wish to buy or sell the cards by naming and shaming them. We are also enhancing the security features of our vaccination cards in order to limit forgery.”

The executive director said the exercise would require strong collaboration between NPHCDA, state governments, religious bodies, school authorities, and governing bodies of malls and large sporting events.

He said, “As we expand the vaccination sites, we encourage all eligible Nigerians to avail themselves for vaccination. I am also glad to inform you that we have commenced the process of decentralising COVID-19 vaccination in Nigeria, to include private health care providers. This is to expand access and increase utilisation of the vaccines.”

Shuaib assured that decentralisation would not affect the federal government’s free vaccination policy, adding that COVID-19 vaccines would be administered free of charge at both government and private health facilities and the vaccination cards would be given free of charge after vaccination.

He, however, noted that private health facilities might need to charge for their hospital registration cards, which would be different from the COVID-19 vaccination cards.

Shuaib said in order to ensure a seamless decentralisation, the agency had begun the training of health workers in selected private health care facilities and the sensitisation of critical stakeholders to create awareness on the plan and criteria for involving the private sector in COVID-19 vaccination.

YOU MAY ALSO LIKE:   COVID-19: Nigeria records 6 deaths, 226 new cases

He said the process of involving the private sector would be transparently done in line with the agency’s pledge of accountability to Nigerians.

On the supervision of private healthcare providers involved in COVID-19 vaccination, the NPHCDA boss said the agency was putting measures in place to ensure close and effective monitoring and supervision of participating private health facilities to ensure standards were not compromised.

He said interested private health facilities would be required to meet certain criteria, including having the requisite qualified health care workers, among others. To ensure delivery of the vaccines by private health facilities as expected, he said the agency would engage in regular supervisory visits to the facilities and provide clear rules of engagement to the participating facilities.

Shuaib gave an update on the vaccination efforts, saying as of the morning of October 14, a total of 5,246,523 eligible populations had received at least one dose of COVID-19 vaccine in Nigeria, representing 4.7 per cent of Nigeria’s target population.

He further said the number of eligible persons fully vaccinated in Nigeria was now 2,546,094, representing 2.3 per cent of the target population.

Shuaib also gave an update on the outcome of the study on the vaccination exercise conducted in six states of the federation, namely Anambra, Borno, Edo, Katsina, Lagos, and Plateau. He said the overall aim of the observational study was to monitor the safety of COVID-19 vaccines in enrolled adult individuals of 18 years and above, who had received the authorised COVID-19 vaccine in Nigeria for the purpose of safety signal detection.

Shuaib disclosed that Professor Akin Osibogun, a Professor of Community Medicine at the Lagos University Teaching Hospital, led the study. He said the study sought to estimate the incidence of adverse events following immunisation with different brands of the COVID-19 vaccine in all enrolled immunised subjects.

Shuaib explained, “Findings of this study showed that 52.6 per cent of enrollees (1,284 were enrolled) reported non-serious adverse effects and only one subject or 0.08 per cent reported serious adverse effects in the first week following vaccination. None of the enrolled subjects, who reported adverse effects, required hospitalisation.

“The commonest reported symptoms among vaccines were tenderness at the injection site (20.9 per cent) and fever (20.3 per cent). Most of the reported symptoms (55.5 per cent) occurred within the first three days of vaccination while 40.2 per cent of the vaccines with reported symptoms could not recall time of onset of symptoms. “

But the adverse effects, he stated, were reported more in the older age groups, with 61.5 per cent of those older than 60 years reporting symptoms compared to 34.9 per cent of those aged 18-24 years.

He said the difference in age was statistically significant (p=0.003).

YOU MAY ALSO LIKE:   FG recommits to support local production of essential medicines

Shuaib stated, “Those with pre-existing morbidities were also observed to have higher rates of reported symptoms (AEFIs) than those without pre-existing morbidities even though the observed difference was not statistically significant (p=0.551)

“The findings suggest that from the perspective of public communication, the vaccine is quite safe and the reported symptoms are mild and to be expected in the first three days following vaccination.

“Older vaccines are to be particularly counselled as to what to expect and not to panic as the symptoms are mild and time-limited. During this study, there was no report of Vaccine-induced COVID-19 or deaths related to the vaccines.”
US Donates over 3.5 million Doses of COVID-19 Vaccine to Nigeria

Meanwhile, the United States has shipped in over 3.5 million doses of COVID-19 vaccines into Nigeria.

A statement yesterday from the US Embassy noted that the US Mission in Nigeria was pleased, “to announce the arrival of 3,577,860 doses of Pfizer vaccine for the public health and benefit of the Nigerian people through COVAX, the worldwide initiative ensuring equitable access to COVID-19 vaccines.”

The statement further disclosed that the US shipment arrived at the Nnamdi Azikiwe International Airport in Abuja on October 14.

According to the statement, the shipment would bring the total number of US-bilaterally donated doses to Nigeria to over 7.5 million, noting that the US also contributed to the first multilateral donation of AstraZeneca vaccine in March 2021.

That meant that overall, COVAX has provided Nigeria with over 10 million doses to date.

“Safe and effective vaccines are our best tool to ending the pandemic. The United States has pledged to purchase and donate 1.1 billion COVID-19 vaccine doses worldwide, and to date has delivered more than 180 million doses to more than 100 countries,” it added.

The US government pointed out that its continued efforts to provide vaccines to African Union (AU) member countries were to fulfil President Biden’s pledge when he said: “The United States is committed to bringing the same urgency to international vaccination efforts that we have demonstrated at home. We are sharing these vaccines to save lives and to lead the world in bringing an end to the pandemic.”

The statement further noted that vaccine donations were part of the US government’s continued partnership with the government of Nigeria in combatting COVID-19.

“To date, the US government has provided $130 million of support to Nigeria’s Ministry of Health and Presidential Steering Committee on COVID-19. The US government is looking forward to continued coordination with Nigeria and its Center for Disease Control to deliver life-saving doses across the country through the COVAX initiative,” it added.

Share With A Friend
Continue Reading

Trending